Spleen‐dedicated stiffness measurement performed well to rule out high‐risk varices in HBV ‐related hepatocellular carcinoma
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.17850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Xiao Cheng und 26 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Esophageal and Gastric Varices, Liver Neoplasms, Varicose Veins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Postdoctoral Program for Innovative Talents of China, Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program.
Abstract (Originalsprache)
Background
Esophagogastroduodenoscopy (EGD) is required to screen for high‐risk varices (HRV) in patients with hepatocellular carcinoma (HCC), especially since overall survival rates have dramatically improved with new systemic therapies.
Aim
To assess the Baveno VI and Baveno VII algorithms' ability to rule out HRV in hepatitis B virus (HBV)‐related HCC Methods We prospectively enrolled consecutive patients with HBV related, compensated cirrhosis and newly diagnosed HCC who underwent liver stiffness measurement, spleen stiffness measurement (SSM) using a 100‐Hz shear wave frequency, and EGD.
Results
From September 2021 to August 2023, we enrolled 219 patients with HCC, with 107 (48.9%) Barcelona Clinic Liver Cancer (BCLC) A, 28 (12.8%) BCLC B and 84 (38.3%) BCLC C, respectively. HRV prevalence was 28.8% (63/219). Baveno VI criteria safely (HRV missing rate, 3.2%) avoided 27.4% unnecessary EGDs, while the Baveno VII algorithm avoided 49.3% with HRV missing rate at 7.9% (5/63). The SSM ≤40 kPa avoided 47.5% of EGDs safely (HRV missing rate, 4.8%), significantly better than the Baveno VI criteria ( p < 0.001) and comparable to the Baveno VII algorithm ( p = 0.390). The SSM ≤40 kPa safely avoided EGDs in patient subgroups within Milan criteria, with portal vein tumour thrombosis or BCLC B/C or candidates for systemic therapy.
Conclusions
We validated that the SSM ≤40 kPa using a 100‐Hz probe could safely eliminate more unnecessary EGDs than the Baveno VI criteria in patients with HBV‐related HCC. However, the efficacy of the Baveno VII algorithm in patients with HCC requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Hepatology, Zengcheng Branch, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Liver Tumor Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Hepatology Unit, Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Nanfang Hospital, Southern Medical University, Guangzh…
ORCID-Profile: Guosheng Yuan, Xiaofeng Zhang
Förderung
- National Natural Science Foundation of China
- National Postdoctoral Program for Innovative Talents of China
- Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program
- Clinical Research Program of Nanfang Hospital, Southern Medical University
- National Science and Technology Major Project
- Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education
- Postdoctoral Science Foundation of China
Zitieren
APA
Cheng, X., Tang, Y., He, Q., Song, J., Wang, K., Li, H., Huang, J., Wang, W., Li, J., Wang, H., Tu, M., Chen, J., Yuan, G., Kang, S., Liu, H., Zhang, X., Luo, W., Ji, Y., Lan, X., …, & Zhang, X. (2024). Spleen‐dedicated stiffness measurement performed well to rule out high‐risk varices in HBV ‐related hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17850
Vancouver
Cheng X, Tang Y, He Q, Song J, Wang K, Li H, et al. Spleen‐dedicated stiffness measurement performed well to rule out high‐risk varices in HBV ‐related hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17850
BibTeX
@article{Cheng2024,
author = {Cheng, Xiao and Tang, Yujun and He, Qinjun and Song, Jiankang and Wang, Kunyuan and Li, Hui and Huang, Jing and Wang, Weibin and Li, Junying and Wang, Haiyu and Tu, Minghan and Chen, Jinzhang and Yuan, Guosheng and Kang, Shuai and Liu, Hongyan and Zhang, Xiaoyong and Luo, Wenfan and Ji, Yali and Lan, Xiaoqin and Zhou, Ling and Lai, Qintao and Luo, Xiaoqin and Wu, Qiaoping and Zhou, Damei and Tan, Yingqi and Chen, Jinjun and Zhang, Xiaofeng},
title = {Spleen‐dedicated stiffness measurement performed well to rule out high‐risk varices in HBV ‐related hepatocellular carcinoma},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.17850}
}
EUVIMED